SG Americas Securities’s 1Life Healthcare ONEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-19,658
| Closed | -$328K | – | 3658 |
|
|
2022
Q4 | $328K | Sell |
19,658
-21,348
| -52% | -$361K | ﹤0.01% | 1858 |
|
|
2022
Q3 | $703K | Buy |
41,006
+17,702
| +76% | +$278K | 0.01% | 1256 |
|
|
2022
Q2 | $183K | Buy |
23,304
+702
| +3% | +$6.03K | ﹤0.01% | 2727 |
|
|
2022
Q1 | $250K | Buy |
22,602
+7,899
| +54% | +$88.5K | ﹤0.01% | 2291 |
|
|
2021
Q4 | $258K | Sell |
14,703
-33,531
| -70% | -$650K | ﹤0.01% | 2533 |
|
|
2021
Q3 | $977K | Buy |
48,234
+34,822
| +260% | +$895K | ﹤0.01% | 1929 |
|
|
2021
Q2 | $443K | Sell |
13,412
-2,141
| -14% | -$80.8K | ﹤0.01% | 1997 |
|
|
2021
Q1 | $608K | Sell |
15,553
-6,653
| -30% | -$312K | ﹤0.01% | 1879 |
|
|
2020
Q4 | $969K | Buy |
+22,206
| New | +$759K | 0.01% | 1554 |
|
|
2020
Q3 | – | Sell |
-12,650
| Closed | -$459K | – | 3681 |
|
|
2020
Q2 | $459K | Buy |
12,650
+5,891
| +87% | +$166K | ﹤0.01% | 2165 |
|
|
2020
Q1 | $123K | Buy |
+6,759
| New | +$148K | ﹤0.01% | 2845 |
|
SG Americas Securities's ONEM Position: Q1 2023 in Review
SG Americas Securities sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 19,658 shares — an estimated $328K sold.
SG Americas Securities first reported a position in ONEM in Q1 2020 and held it in 11 quarters. The position peaked at $977K in Q3 2021. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.
- SG Americas Securities reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
- SG Americas Securities sold 19,658 1Life Healthcare shares in Q1 2023, an estimated $328K.
- SG Americas Securities first reported a position in 1Life Healthcare in Q1 2020 and held it in 11 quarters.
- SG Americas Securities's 1Life Healthcare position peaked at $977K in Q3 2021.
- 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.
Based on SG Americas Securities's 13F filing for Q1 2023, filed 28 Apr 2023.